Results for tag: "Mekinist"

Mekinist (Trametinib) is an oncology drug used to treat certain types of cancer, such as melanoma and non-small cell lung cancer. It is a kinase inhibitor, meaning it works by blocking certain proteins that help cancer cells grow and divide. Mekinist is typically used in combination with other drugs, such as dabrafenib, to treat advanced melanoma. It is also used to treat non-small cell lung cancer that has spread to other parts of the body. Mekinist is approved by the U.S. Food and Drug Administration (FDA) and is available in both tablet and injection form. The Mekinist market is a rapidly growing segment of the oncology drug market. It is driven by the increasing prevalence of cancer, as well as the development of new and more effective treatments. The market is highly competitive, with a number of companies offering Mekinist and other kinase inhibitors. Some of the major players in the Mekinist market include Novartis, GlaxoSmithKline, Pfizer, and Merck. Show Less Read more